HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideshi Ishii Selected Research

Aldehyde Dehydrogenase

4/2013Depletion of JARID1B induces cellular senescence in human colorectal cancer.
4/2013Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideshi Ishii Research Topics

Disease

134Neoplasms (Cancer)
04/2024 - 03/2002
36Colorectal Neoplasms (Colorectal Cancer)
01/2024 - 07/2004
27Neoplasm Metastasis (Metastasis)
04/2024 - 12/2004
17Pancreatic Neoplasms (Pancreatic Cancer)
04/2024 - 11/2004
11Adenocarcinoma
03/2024 - 01/2013
10Stomach Neoplasms (Stomach Cancer)
08/2013 - 01/2006
9Carcinogenesis
08/2018 - 01/2003
8Breast Neoplasms (Breast Cancer)
01/2019 - 03/2003
7Gastrointestinal Neoplasms (Gastrointestinal Cancer)
08/2023 - 08/2015
6Colonic Neoplasms (Colon Cancer)
01/2019 - 12/2008
6Leukemia
02/2015 - 05/2003
6Esophageal Neoplasms (Esophageal Cancer)
07/2013 - 10/2004
4Inflammation (Inflammations)
04/2024 - 03/2006
4Cholangiocarcinoma
01/2023 - 04/2010
4Hepatocellular Carcinoma (Hepatoma)
01/2019 - 11/2012
4Liver Neoplasms (Liver Cancer)
11/2012 - 09/2010
4Lymphatic Metastasis
11/2010 - 09/2010
4Carcinoma (Carcinomatosis)
05/2007 - 03/2002
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2024 - 07/2022
3Hypoxia (Hypoxemia)
02/2018 - 09/2010
2Colitis
04/2024 - 07/2022
2Lung Neoplasms (Lung Cancer)
10/2023 - 01/2006
2Ataxia Telangiectasia (Louis Bar Syndrome)
01/2022 - 03/2005
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 06/2005
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2016 - 10/2004
2Hematologic Neoplasms (Hematological Malignancy)
03/2015 - 10/2008
2Urinary Bladder Neoplasms (Bladder Cancer)
04/2008 - 11/2004

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
03/2024 - 05/2003
22MicroRNAs (MicroRNA)IBA
08/2023 - 04/2011
18Messenger RNA (mRNA)IBA
04/2024 - 11/2003
17EnzymesIBA
04/2024 - 07/2004
17RNA (Ribonucleic Acid)IBA
01/2024 - 10/2004
12Indicators and Reagents (Reagents)IBA
08/2023 - 01/2006
11Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2003
10CarbonIBA
10/2021 - 11/2015
10Histidine (L-Histidine)FDA Link
07/2009 - 03/2002
76-methyladenineIBA
04/2024 - 01/2018
7Transcription Factors (Transcription Factor)IBA
08/2023 - 10/2011
7CarcinogensIBA
06/2012 - 09/2003
6Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 09/2010
5DNA (Deoxyribonucleic Acid)IBA
10/2022 - 05/2007
5Folic Acid (Vitamin M)FDA LinkGeneric
07/2021 - 01/2017
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2024 - 12/2004
4Trifluridine (Viroptic)FDA LinkGeneric
01/2022 - 04/2017
4Reactive Oxygen Species (Oxygen Radicals)IBA
07/2021 - 07/2012
4Small Interfering RNA (siRNA)IBA
02/2018 - 03/2006
4Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
01/2018 - 03/2014
4Pyruvate KinaseIBA
08/2015 - 10/2014
4Complementary DNA (cDNA)IBA
06/2012 - 11/2004
4fragile histidine triad proteinIBA
05/2007 - 03/2002
4nitrosobenzylmethylamineIBA
03/2005 - 01/2003
3CytokinesIBA
09/2023 - 05/2013
3Matrix Metalloproteinases (MMPs)IBA
09/2023 - 12/2008
3NucleotidesIBA
08/2023 - 11/2003
3Peptide Hydrolases (Proteases)FDA Link
01/2019 - 12/2004
3GemcitabineFDA Link
01/2019 - 09/2015
3Epidermal Growth Factor (EGF)IBA
08/2015 - 12/2004
3A-Form DNA (A-DNA)IBA
08/2013 - 11/2003
2Neuropilin-1IBA
03/2024 - 01/2019
2Long Noncoding RNAIBA
10/2023 - 02/2018
2InterferonsIBA
01/2023 - 08/2014
2Cyclin-Dependent Kinase Inhibitor p16IBA
10/2022 - 04/2013
2N-methyladenosineIBA
01/2022 - 01/2021
2LigandsIBA
01/2020 - 12/2004
2Monocarboxylic Acid TransportersIBA
04/2019 - 03/2018
2PolyaminesIBA
01/2019 - 01/2018
2Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 08/2017
2Methylenetetrahydrofolate Dehydrogenase (NADP) (Dehydrogenase, Methylenetetrahydrofolate)IBA
12/2018 - 01/2017
2HydrolasesIBA
04/2017 - 02/2003
2Serine (L-Serine)FDA Link
04/2017 - 01/2017
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
11/2016 - 03/2015
2Histones (Histone)IBA
11/2016 - 11/2003
2RibonucleotidesIBA
11/2015 - 01/2015
2HexokinaseIBA
05/2015 - 09/2014
2Green Fluorescent ProteinsIBA
12/2014 - 12/2014
2AntibodiesIBA
09/2014 - 04/2014
2Epithelial Cell Adhesion MoleculeIBA
04/2014 - 04/2013
2Transforming Growth Factor beta (TGF-beta)IBA
05/2013 - 12/2004
2Aldehyde DehydrogenaseIBA
04/2013 - 04/2013
2Cadherins (E-Cadherin)IBA
07/2012 - 09/2010
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
02/2011 - 10/2008
2teleocalcinIBA
01/2011 - 10/2010
2Tumor Biomarkers (Tumor Markers)IBA
12/2010 - 07/2009
2AntigensIBA
02/2010 - 07/2009
2Caspase 3 (Caspase-3)IBA
07/2009 - 10/2004
2CamptothecinIBA
12/2008 - 05/2007
2Matrix Metalloproteinase 14 (MT1-MMP)IBA
12/2008 - 10/2008
2Mitomycin (Mitomycin-C)FDA LinkGeneric
12/2008 - 05/2007
2NitrosaminesIBA
04/2008 - 11/2004
2Histone Deacetylase InhibitorsIBA
01/2006 - 05/2005
2Phosphotransferases (Kinase)IBA
01/2006 - 03/2005
2DepsipeptidesIBA
01/2006 - 05/2005
2romidepsin (FK228)FDA Link
01/2006 - 05/2005
2Histone Deacetylases (Histone Deacetylase)IBA
01/2006 - 05/2005
2Tyrosine Kinase InhibitorsIBA
01/2006 - 12/2004

Therapy/Procedure

38Therapeutics
03/2024 - 03/2004
18Drug Therapy (Chemotherapy)
08/2023 - 07/2010
9Radiotherapy
08/2023 - 09/2010
5Precision Medicine
04/2022 - 04/2017
4Lasers (Laser)
06/2012 - 05/2007